Drug profile · INN
halcinonide
HALOG-E
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
halcinonide (HALOG-E) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12377068
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted -
US 12252714
Halogenation of complex organic compounds
granted -
US 12138276
Halogenated psilocybin derivatives and methods of using
granted -
US 12133840
Halogenated xanthene composition and method for treating hematologic cancers
granted -
US 11998557
Halogenated psilocybin derivatives and methods of using
granted -
US 11974980
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11975106
Uses of halogenated xanthenes in oncology and virology
granted
Frequently asked questions
What is halcinonide?
halcinonide (HALOG-E) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for halcinonide?
HALOG-E is a marketed brand name for halcinonide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of halcinonide?
halcinonide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.